Stock EARUM MURAE ORGANISOR LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Murae Organisor Limited

Equities

EARUM

INE060601023

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 07:45:00 27/06/2024 BST 		5-day change 1st Jan Change
1.42 INR +1.43% Intraday chart for Murae Organisor Limited -2.74% +23.48%
05-30 Murae Organisor Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
05-29 Murae Organisor Limited announced that it has received INR 247.499999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited CI

Valuation

Fiscal Period: March 2020 2021 2022 2023
Capitalization 1 293.3 462.9 334.3 130.1
Enterprise Value (EV) 1 385.9 575.6 431.1 217.3
P/E ratio 16.2 x 536 x 15 x 6.57 x
Yield - - - -
Capitalization / Revenue 0.53 x 1.13 x 1.59 x 0.92 x
EV / Revenue 0.7 x 1.4 x 2.05 x 1.54 x
EV / EBITDA 11 x 52.4 x 13.1 x 6.81 x
EV / FCF -10.4 x -11.3 x 34.9 x 29.8 x
FCF Yield -9.59% -8.86% 2.86% 3.36%
Price to Book 2.03 x 3.19 x 2 x 0.7 x
Nbr of stocks (in thousands) 61,679 61,679 61,679 61,679
Reference price 2 4.755 7.505 5.420 2.110
Announcement Date 05/12/20 11/08/21 06/08/22 13/10/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 354.4 507 551.1 410.8 210.4 140.9
EBITDA 1 16.18 33.54 35.11 10.98 32.82 31.9
EBIT 1 15.96 33.16 34.11 9.751 31.64 30.86
Operating Margin 4.5% 6.54% 6.19% 2.37% 15.04% 21.9%
Earnings before Tax (EBT) 1 12.41 22.77 24.45 1.177 30.82 27.95
Net income 1 8.565 16.61 18.15 0.8824 22.24 19.81
Net margin 2.42% 3.28% 3.29% 0.21% 10.57% 14.06%
EPS 2 0.3503 0.3845 0.2943 0.0140 0.3610 0.3210
Free Cash Flow 1 -80.45 -17.79 -37.01 -51 12.34 7.303
FCF margin -22.7% -3.51% -6.72% -12.41% 5.87% 5.18%
FCF Conversion (EBITDA) - - - - 37.61% 22.9%
FCF Conversion (Net income) - - - - 55.5% 36.86%
Dividend per Share - - - - - -
Announcement Date 10/04/19 04/09/19 05/12/20 11/08/21 06/08/22 13/10/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 72 94.2 92.6 113 96.8 87.1
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 4.454 x 2.809 x 2.636 x 10.27 x 2.949 x 2.732 x
Free Cash Flow 1 -80.5 -17.8 -37 -51 12.3 7.3
ROE (net income / shareholders' equity) 27.4% 30.6% 17.8% 0.61% 14.2% 11.2%
ROA (Net income/ Total Assets) 6.31% 9.69% 7.18% 1.9% 6.98% 6.72%
Assets 1 135.7 171.4 252.9 46.35 318.7 294.7
Book Value Per Share 2 1.100 1.380 2.340 2.350 2.710 3.030
Cash Flow per Share 2 0.0100 0.0400 0 0.0100 0.0100 0
Capex 1 0.57 3.18 4.21 0.88 - -
Capex / Sales 0.16% 0.63% 0.76% 0.21% - -
Announcement Date 10/04/19 04/09/19 05/12/20 11/08/21 06/08/22 13/10/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
MURAE ORGANISOR LIMITED Stock Murae Organisor Limited
+23.48% 4.14M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.61% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.00% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.62% 333B
ABBVIE INC. Stock AbbVie Inc.
+10.44% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.32% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.58% 225B
NOVARTIS AG Stock Novartis AG
+12.90% 218B
AMGEN INC. Stock Amgen Inc.
+8.61% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. EARUM Stock
  4. Financials Murae Organisor Limited